• RUPA YADAV

The 17 billion dollar Indian Pharmaceutical Industry is one of the fastest growing sectors in the country, growing at a growth rate of 9.4 per cent year on year. It has become the 3rd largest market in the world by way of volume and 13th largest in value. It is expected to grow at a Compounded Annual Growth Rate (CAGR) of 15 per cent in near future. There are 20000 registered units comprising organised as well as unorganised players and MNCs. An efficient asset management is expected to contribute positively toward the creation of a firm’s value s. In the present paper an attempt has been made to examine the trend in the efficiency of asset management in the selected Indian Pharmaceutical Companies, consistency in the efficiency of asset management and contribution of such efficiency of assets management in value generating capability of the selected Pharmaceutical firms. For this purpose a cross-sectional analysis has been conducted in respect of assets management efficiency of selected pharmaceutical companies during the period 2001-02 to 2015-16.

Asset Management Efficiency, Value Generating Capability, CAGR

"Trends in Asset Management Efficiency in Selected Pharmaceutical Companies: A Cross-sectional Analysis", International Journal of Emerging Technologies and Innovative Research (www.jetir.org), ISSN:2349-5162, Vol.6, Issue 5, page no.500-507, May-2019, Available :http://www.jetir.org/papers/JETIR1905172.pdf

"Trends in Asset Management Efficiency in Selected Pharmaceutical Companies: A Cross-sectional Analysis", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.6, Issue 5, page no. pp500-507, May-2019, Available at : http://www.jetir.org/papers/JETIR1905172.pdf